Jane Street Group, LLC Corcept Therapeutics Inc Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Jane Street Group, LLC holds 55,626 shares of CORT stock, worth $3.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

55,626

Previous 144,141 61.41%

Holding current value

$3.2 Million

Previous $4.68 Million 45.06%

% of portfolio

0.0%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$29.51 - $46.26 $2.61 Million - $4.09 Million	-88,515 Reduced 61.41%	55,626 $2.57 Million
Q2 2024 Aug 14, 2024	BUY	$22.21 - $34.48 $2.8 Million - $4.35 Million	126,207 Added 703.73%	144,141 $4.68 Million
Q1 2024 May 15, 2024	SELL	$21.1 - $27.46 $1.55 Million - $2.01 Million	-73,244 Reduced 80.33%	17,934 $451,000
Q4 2023 Feb 14, 2024	BUY	$24.82 - $32.88 $598,211 - $792,473	24,102 Added 35.93%	91,178 $2.96 Million
Q3 2023 Nov 14, 2023	SELL	$21.97 - $33.8 $602,878 - $927,505	-27,441 Reduced 29.03%	67,076 $1.83 Million
Q2 2023 Aug 14, 2023	BUY	$21.44 - $25.15 $1.32 Million - $1.54 Million	61,413 Added 185.52%	94,517 $2.1 Million
Q1 2023 May 15, 2023	BUY	$19.2 - $24.47 $391,852 - $499,408	20,409 Added 160.76%	33,104 $717,000
Q4 2022 Feb 14, 2023	SELL	$19.95 - $29.96 $798,558 - $1.2 Million	-40,028 Reduced 75.92%	12,695 $257,000
Q3 2022 Nov 14, 2022	SELL	$24.7 - $29.12 $393,693 - $464,143	-15,939 Reduced 23.21%	52,723 $1.35 Million
Q2 2022 Aug 16, 2022	SELL	$17.33 - $25.3 $439,575 - $641,734	-25,365 Reduced 26.98%	68,662 $1.63 Million
Q1 2022 May 17, 2022	SELL	$16.53 - $25.21 $139,695 - $213,049	-8,451 Reduced 8.25%	94,027 $2.12 Million
Q4 2021 Feb 15, 2022	BUY	$17.1 - $23.34 $1.38 Million - $1.88 Million	80,734 Added 371.29%	102,478 $2.03 Million
Q2 2021 Aug 16, 2021	SELL	$19.97 - $24.43 $1.8 Million - $2.21 Million	-90,308 Reduced 80.59%	21,744 $478,000
Q3 2020 Nov 17, 2020	BUY	$12.46 - $19.98 $1.4 Million - $2.24 Million	112,052 New	112,052 $1.95 Million
Q4 2019 Feb 14, 2020	SELL	$12.06 - $16.96 $123,096 - $173,110	-10,207 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$10.41 - $14.66 $106,254 - $149,634	10,207 New	10,207 $144,000
Q2 2019 Aug 15, 2019	SELL	$9.78 - $12.76 $119,707 - $156,182	-12,240 Closed	0 $0
Q1 2019 May 16, 2019	SELL	$10.03 - $15.71 $1.15 Million - $1.8 Million	-114,617 Reduced 90.35%	12,240 $144,000
Q4 2018 Feb 15, 2019	BUY	$11.29 - $17.19 $1.43 Million - $2.18 Million	126,857 New	126,857 $1.7 Million
Q1 2018 May 15, 2018	SELL	$14.59 - $25.5 $364,166 - $636,480	-24,960 Closed	0 $0
Q4 2017 Feb 15, 2018	SELL	$15.77 - $20.72 $364,823 - $479,336	-23,134 Reduced 48.1%	24,960 $451,000
Q3 2017 Nov 14, 2017	BUY	$12.3 - $19.3 $591,556 - $928,214	48,094	48,094 $928,000

Others Institutions Holding CORT

# of Institutions

347

Shares Held

86.6M

Call Options Held

1.12M

Put Options Held

667K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $6.16B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Corcept Therapeutics Inc Transaction History